MedTrace Logo

Radicle Relaxation 24: A Study of Health and Wellness Products on Stress and Related Health Outcomes

NCT06378801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1700

Last updated 2025-11-03

No results posted yet for this study

Summary

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on stress and related health outcomes

Conditions

  • Stress

Interventions

DIETARY_SUPPLEMENT

Placebo Control Form 1

Participants will use their Placebo Control Form 1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Relaxation Active Study Product 1.1

Participants will use their Radicle Relaxation Active Study Product 1.1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Placebo Control Form 2

Participants will use their Placebo Control Form 2 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Relaxation Active Study Product 2.1

Participants will use their Radicle Relaxation Active Study Product 2.1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Placebo Control Form 3

Participants will use their Placebo Control Form 3 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Relaxation Active Study Product 3.1

Participants will use their Radicle Relaxation Active Study Product 3.1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Placebo Control Form 4

Participants will use their Placebo Control Form 4 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Relaxation Active Study Product 4.1

Participants will use their Radicle Relaxation Active Study Product 4.1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Relaxation Active Study Product 4.2

Participants will use their Radicle Relaxation Active Study Product 4.2 as directed for a period of 6 weeks.

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Emily K. Pauli, PharmD · Radicle Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2024-11-01
Completion
2024-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06378801 on ClinicalTrials.gov